Appili Therapeutics Inc. (TSX:APLI)
Canada · Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
Jun 3, 2026, 9:30 AM EST
Appili Therapeutics Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 0.21 | 0.1 | 0.83 | 0.33 | 1.39 | - | |
Revenue Growth (YoY) | 65.38% | -87.86% | 147.59% | -75.97% | - | - |
Gross Profit | 0.21 | 0.1 | 0.83 | 0.33 | 1.39 | - |
Selling, General & Admin | 2.46 | 2.85 | 3.05 | 4.44 | 4.61 | 4.79 |
Research & Development | 3.9 | 7.32 | 5.62 | 3.62 | 20.74 | 10.22 |
Other Operating Expenses | 3.24 | 9.9 | 6.1 | 0.32 | 1.77 | 1.94 |
Total Operating Expenses | 9.6 | 20.08 | 14.77 | 8.39 | 27.13 | 16.95 |
Operating Income | -9.39 | -19.98 | -13.94 | -8.05 | -25.74 | -16.95 |
Interest Income | - | 0 | 0.02 | 0.03 | 0.03 | 0.12 |
Interest Expense | -1.86 | -3.5 | -1.63 | -1.1 | -1.55 | -0.07 |
Other Non-Operating Income (Expense) | -0.51 | 1.74 | -0.07 | 0.36 | -0.06 | - |
Total Non-Operating Income (Expense) | -2.37 | -1.76 | -1.68 | -0.7 | -1.58 | 0.05 |
Pretax Income | -11.76 | -21.74 | -15.62 | -8.75 | -27.32 | -16.9 |
Provision for Income Taxes | 0.1 | 0.02 | 0.07 | 0.04 | 0.04 | - |
Net Income | -2.96 | -2.62 | -3.78 | -9.24 | -25.12 | -14.33 |
Net Income to Common | -2.96 | -2.62 | -3.78 | -9.24 | -25.12 | -14.33 |
Shares Outstanding (Basic) | 123 | 121 | 121 | 114 | 67 | 59 |
Shares Outstanding (Diluted) | 123 | 121 | 121 | 114 | 67 | 59 |
Shares Change (YoY) | 1.46% | - | 6.62% | 70.43% | 12.76% | 74.81% |
EPS (Basic) | -0.03 | -0.02 | -0.03 | -0.08 | -0.38 | -0.24 |
EPS (Diluted) | -0.03 | -0.02 | -0.03 | -0.08 | -0.38 | -0.24 |
Shares Outstanding | 121.27 | 121.27 | 121.27 | 121.27 | 71.27 | 62.78 |
Free Cash Flow | -0.01 | 0.87 | -2.49 | -10.1 | -19.08 | -11.46 |
Free Cash Flow Per Share | -0.00 | 0.01 | -0.02 | -0.09 | -0.29 | -0.19 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - |
Operating Margin | -4551.33% | -19891.20% | -1684.49% | -2409.73% | -1851.00% | - |
Profit Margin | -5750.94% | -21658.90% | -1895.93% | -2630.56% | -1967.23% | - |
FCF Margin | -5.49% | 862.63% | -301.44% | -3022.65% | -1372.07% | - |
EBITDA | -9.38 | -19.97 | -13.92 | -8.05 | -25.73 | -16.93 |
EBITDA Margin | -4546.45% | -19877.80% | -1682.84% | -2407.85% | -1850.09% | - |
EBIT | -9.39 | -19.98 | -13.94 | -8.05 | -25.74 | -16.95 |
EBIT Margin | -4551.33% | -19891.20% | -1684.49% | -2409.73% | -1851.00% | - |
Effective Tax Rate | -0.88% | -0.09% | -0.45% | -0.42% | -0.14% | 0.00% |